InnoSIGN Alternatives & Competitors
12 companies similar to InnoSIGN — Comprehensive Pathway Analysis
Companies similar to InnoSIGN
Genomics
Transforming health, healthcare and drug discovery and development through the power of ge...
Oxford, United Kingdom
Celldom, Inc.
Find and study cells that make diseases incurable
San Carlos, United States
Parallel Bio
Using the immune system to cure disease.
Watertown, United States
Galatea Bio Inc.
Harnessing diversity to advance biopharma discovery and precision medicine
Miami Lakes, United State...
Rival Readout
Competing with InnoSIGN? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Ozette
Unlocking the power of the immune system through computationally-driven analytics
Seattle, United States
Rubedo Life Sciences
Medicines to keep you biologically young by targeting the pathological cells that drive ch...
Sunnyvale, United States
-logo.jpg "MindWalk Corp. (formerly BioStrand)"){kind=logo}
MindWalk Corp. (formerly BioStrand)
This page is no longer actively updated. For future updates follow: MindWalk Holdings Corp...
Austin, United States
PharmEnable Therapeutics
Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innova...
Cambridge, United Kingdom
Engitix Therapeutics
Decoding the ECM space to unlock unprecedented therapies for chronic diseases
London, United Kingdom
BioAge Labs
We are harnessing the biology of human aging to develop novel targets and therapies for me...
Emeryville, United States
AgenT
Detect Alzheimer's earlier, when it could be prevented
Paris, France
Ignota Labs
Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects a...
Cambridge, United Kingdom
About InnoSIGN
InnoSIGN, founded in 2022 and headquartered in The Netherlands, is a dynamic player in the Biotechnology and Life Sciences industries. The company’s tagline, "Comprehensive Pathway Analysis," encapsulates its mission to revolutionize disease understanding. InnoSIGN’s distinguishing feature is its biology-first approach...
Comprehensive Disease Analysis, Data Interpretation from Omics, Actionable Insights for Drug Development
Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Professionals
Biotech, Precision Medicine, Pathway Analysis, MRNA Profiling, Signaling Pathways, Disease Driver Events, Machine Learning In Biotech, Diagnostics, Oncology, Molecular Diagnostics, Drug Discovery, Genomics, QPCR Tests, Structured ML Algorithms, Service Testing Facility
B2B, SaaS, Platform
Subscription, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around InnoSIGN: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at InnoSIGN on 21 May 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
